|
| Issue Date | Title | Author(s) |
| 15-Nov-2019 | 1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC | Dokla, Eman ; Fang, Chun Sheng; Chen, Ching S.; Abouzid, Khaled |
| Jan-2013 | 3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity | Khaled A M Abouzid ; Khalil, Nadia A; Ahmed, Eman M; Mohamed, Khaled Omar |
| Aug-2019 | 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation | Sobhy, Mahitab K; Mowafy, Samar; Lasheen, Deena S. ; Farag, Nahla A; Khaled A M Abouzid |
| 2013 | 4-Substitutedphthalazines and phthalazinones: synthesis, characterization and beta-adrenergic blocking activity | Abouzid, Khaled ; Khalil, NA; Ahmed, E.M. |
| Sep-2007 | 6-aryl-4-oxohexanoic acids: synthesis, effects on eicosanoid biosynthesis, and anti-inflammatory in vivo-activities | Abouzid, Khaled ; Frohberg, Petra; Lehmann, Jochen; Decker, Michael |
| Nov-2012 | A highly selective structure-based virtual screening model of Palm I allosteric inhibitors of HCV Ns5b polymerase enzyme and its application in the discovery and optimization of new analogues | Mahmoud, Amr H; Ismail, Mohamed A H; Abouzid, Khaled ; Abou El Ella, Dalal |
| 15-May-2009 | ACE inhibitors hypothesis generation for selective design, synthesis and biological evaluation of 3-mercapto-2-methyl-propanoyl-pyrrolidine-3-imine derivatives as antihypertensive agents | Ismail, Mohamed A H; Nabil Aboul-Enein, M; Abouzid, Khaled ; Ismail, Nasser S M; Abou El Ella, Dalal |
| 2018 | Acrylamide moiety, a Valuable Fragment in Medicinal Chemistry: Insight into Synthetic Methodologies, Chemical Reactivity and Spectrum of Biological Activities of Acrylamide Derivatives | Elgiushy, Hossam; Hammad, Sherif; Hassan, Ashraf; Aboutaleb, Nageh; Abouzid, Khaled |
| 25-May-2018 | Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens | ElAwamy, Moustafa; Mohammad, Haroon; Hussien, Abdelrahman; Abutaleb, Nader S; Hagras, Mohamed; Serya, Rabah ; Taher, Azza T; Seleem, Mohamed N; Mayhoub, Abdelrahman S; Khaled A M Abouzid |
| 2023 | AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase | Nada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled ; Dokla, Eman ; Serya, Rabah |
| 15-May-2013 | Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity | Lasheen, Deena S. ; Ismail, Mohamed A H; Ismail, Nasser S M; Eid, Sameh; Vleck, Susan; Glenn, Jeffrey S; Watts, Andrew G; Abouzid, Khaled ; Abou El Ella, Dalal |
| 1-Sep-2021 | Antimicrobial and Cytotoxicity Evaluation of New 3-Allyl-2-iminothiazolidin-4-ones | Hammad, Shaymaa G.; El-Gazzar, Marwa G.; Abdel-Halim, Mohammad; Elrazaz, Eman ; El-Hossary, Ebaa M.; Khaled A M Abouzid |
| 31-Oct-2005 | Antipyretic, antinociceptive and anti-inflammatory activities of certain γ-oxobutanoic acid derivatives | Abouzid, Khaled ; Youssef, Khairia M.; Ahmed, Amany A.E.; Al-Zuhair, Hanaa Hussain |
| 27-Nov-2012 | Applying Ligands Profiling Using Multiple Extended Electron Distribution Based Field Templates and Feature Trees Similarity Searching in the Discovery of New Generation of Urea-Based Antineoplastic Kinase Inhibitors | Dokla, Eman ; Mahmoud, Amr H.; Elsayed, Mohamed S.A.; El-Khatib, Ahmed H.; Linscheid, Michael W.; Khaled A M Abouzid |
| Mar-2013 | Assessment of new anti-HER2 ligands using combined docking, QM/MM scoring and MD simulation | Ahmed, Marawan; Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Wang, Feng; Khaled A M Abouzid |
| 1-Nov-2011 | Baclofen ester and carbamate prodrug candidates: a simultaneous chromatographic assay, resolution optimized with DryLab | Hanafi, Rasha; Mosad, Salwa; Abouzid, Khaled ; Niess, Raimund; Spahn-Langguth, Hilde |
| Sep-2018 | Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer | Hesham, Heba M; Lasheen, Deena S. ; Khaled A M Abouzid |
| 30-Jan-2017 | Click and Release: SO2 Prodrugs with Tunable Release Rates | Serya, Rabah ; Khaled A.M.abouzid; Deena S.Lasheen; Xingyue Ji; Binghe Wang; Khaled A M Abouzid |
| 2010 | Computer - based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2 '-carbethoxy-biphenylylmethyl moeities as alpha(1)-adrenoceptor antagonists and angiotensin II AT(1) receptor antagonists | Ismail, MAH; Abouzid, Khaled ; Al-Ansary, GHA; Abou El Ella, Dalal |
| Aug-2016 | Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical Profiles | Hossam, Monia; Lasheen, Deena S. ; Abouzid, Khaled |
| Nov-2016 | Design and Synthesis of 4-Anilinothieno[2,3-d]pyrimidine-Based Compounds as Dual EGFR/HER-2 Inhibitors | Abd El Hadi, Soha R; Lasheen, Deena S. ; Hassan, Mahmoud A; Khaled A M Abouzid |
| 25-Mar-2019 | Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers | El Newahie, Aliya M S; Nissan, Yassin M; Ismail, Nasser S M; Abou El Ella, Dalal ; Khojah, Sohair M; Abouzid, Khaled |
| 9-Mar-2006 | Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists | Ismail, Mohamed A H; Barker, Stewart; Abou El Ella, Dalal ; Abouzid, Khaled ; Toubar, Rabab A; Todd, Matthew H |
| 1-Jun-2018 | Design, synthesis and 3D QSAR based pharmacophore study of novel imatinib analogs as antitumor-apoptotic agents | Fawzy, Iten M; Youssef, Khairia M; Lasheen, Deena S. ; Ismail, Nasser Sm; Abouzid, Khaled |
| 2008 | Design, synthesis and anti-inflammatory activity of 3-arylethenyl-6-substituted-pyridazines | Khaled A M Abouzid ; Nadia A Khalil; Eman M Ahmed; Hekmat A. Abd El-Latif |
| 16-Jul-2007 | DESIGN, SYNTHESIS AND ANTIHYPERTENSIVE ACTIVITY OF CERTAIN PYRAZOLOPYRIMIDINES WITH ARYLPIPERAZINE SIDE CHAINS. | Khaled A M Abouzid ; Azza Taher; Hanan Kadry |
| Dec-2020 | Design, synthesis and biological evaluation of a new thieno[2,3-d]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines | Sharaky, Marwa; Kamel, Marwa; Aziz, Marwa A; Omran, Mervat; Rageh, Monira M; Abouzid, Khaled ; Shouman, Samia A |
| 2016 | Design, synthesis and biological evaluation of indazole–pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activities | Elsayed, Nevine M. Y.; Abou El Ella, Dalal ; Serya, Rabah A. T. ; Tolba, Mai F.; Shalaby, Raed; Khaled A M Abouzid |
| 2015 | Design, synthesis and biological evaluation of Novel Curcumin Analogs with anticipated anticancer activity | Fawzy, IM; Youssef, KM; Ismail, NSM; Gullbo, J; Abouzid, Khaled |
| 15-Aug-2009 | Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors | Abadi, Ashraf H; Ibrahim, Tamer M; Khaled A M Abouzid ; Lehmann, Jochen; Tinsley, Heather N; Gary, Bernard D; Piazza, Gary A |
| Oct-2014 | Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold | Abou El Ella, Dalal ; Ismail, Nasser S M; Abouzid, Khaled ; Shahin, Mai I. |
| 16-Jul-2007 | DESIGN, SYNTHESIS AND BLOOD PRESSURE LOWERING ACTIVITY OF CERTAIN TETRAHYDROBENZO [b] THIOPHENE DERIVATIVES WITH ARYLPIPERAZINYL SIDE CHAINS | Khaled A M Abouzid ; Azza Taher; Mona M. Kamel |
| 10-Aug-2020 | Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors | Ramadan, Sayed ; Elrazaz, Eman ; Khaled A M Abouzid ; El- naggar, Abeer |
| Mar-2013 | Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors | Mowafy, Samar; Farag, Nahla A; Abouzid, Khaled |
| 15-Aug-2008 | Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase | Abouzid, Khaled ; Shouman, Samia |
| 2019 | Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors | Oudah, Khulood H; Najm, Mazin A A; Samir, Nermin ; Serya, Rabah ; Khaled A M Abouzid |
| Mar-2019 | Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents | Ghith, Amna; Youssef, Khairia M; Ismail, Nasser S M; Abouzid, Khaled |
| 2012 | DESIGN, SYNTHESIS AND VIRTUAL SCREENING OF CERTAIN 2-PYRAZOLIN-5-ONE AND PYRAZOLIDINE-3, 5-DIONE DERIVATIVES AS POTENTIAL PPAR gamma AGONISTS | Ismaila, MAH; El Ella, DAA; Abouzid, Khaled ; Jaballah, M |
| Dec-2014 | Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents | Abdel-Atty, Mona M; Farag, Nahla A; Kassab, Shaymaa E; Serya, Rabah ; Khaled A M Abouzid |
| 2015 | Design, synthesis, and antihypertensive evaluation of 2 '-tetrazolyl and 2 '-carboxy-biphenylylmethyl-pyrrolidine scaffolds substituted at their N-1, C-3, and C-4 positions as potential angiotensin II AT(1) receptor antagonists | Ismail, MAH; Aboul-Enein, MN; El-Azzouny, AA; Abouzid, Khaled ; Ismail, NSM |
| Dec-2022 | Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study | Elmenier, Fatma M; Lasheen, Deena ; Abouzid, Khaled |
| 18-Aug-2020 | Design, Synthesis, and Biological Evaluation of Novel 7H-[1,2,4]Triazolo[3,4-b][1,3,4]thiadiazine Inhibitors as Antitumor Agents | Ismail, Muhammad I; Mohamady, Samy; Abouzid, Khaled ; Nermin Samir |
| 1-Nov-2012 | Design, synthesis, and evaluation of anti-inflammatory and ulcerogenicity of novel pyridazinone derivatives | Khalil, N. A.; Ahmed, E.M. ; Ahmed Esmat ; Al-Abd, A. M.; Khaled A M Abouzid |
| 2019 | Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity | Elsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid |
| Jan-2020 | Design, synthesis, biological evaluation and molecular modeling study of new thieno[2,3-d]pyrimidines with anti-proliferative activity on pancreatic cancer cell lines | Salem, Mohamed S H; Abdel Aziz, Yasmine M; Elgawish, Mohamed S; Said, Mohamed M; Abouzid, Khaled |
| 2018 | Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents | Hesham, Heba; Lasheen, Deena S. ; Abouzid, Khaled |
| 15-Jan-2020 | Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria | Abutaleb, Nader S; Milik, Sandra N; Li, Daoyi; El-Baz, Karim; Shalaby, Menna-Allah W; Al-Karaki, Rawan; Nasr, Maha ; Klein, Christian D; Seleem, Mohamed N; Dokla, Eman ; Khaled A M Abouzid |
| Nov-2015 | Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators | Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah ; Ismail, Nasser S M; Chen, Ching-Shih; Dokla, Eman ; Khaled A M Abouzid |
| 15-Feb-2022 | Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia | Dokla, Eman ; Abdel-Aziz, Amal Kamal ; Milik, Sandra N.; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| Dec-2022 | Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity | Abdel-Aziz, Amal Kamal ; Khaled A M Abouzid ; Minucci, Saverio; Dokla, Eman |
| Apr-2014 | Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents | Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Ahmed, Marawan; Wang, Feng; Khaled A M Abouzid |
| Dec-2015 | Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors | El-labbad, Eman M; Ismail, Mohammed A H; Abou Ei Ella, Dalal A; Ahmed, Marawan; Wang, Feng; Barakat, Khaled H; Abouzid, Khaled |
| 21-Oct-2016 | Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality | Osman, Noha A; Ligresti, Alessia; Klein, Christian D; Allarà, Marco; Rabbito, Alessandro; Di Marzo, Vincenzo; Abouzid, Khaled ; Abadi, Ashraf H |
| Jun-2015 | Discovery of novel tricyclic pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine derivatives as VEGFR-2 inhibitors | Abdel Aziz, Yasmine M; Said, Mohamed M; El Shihawy, Hosam A; Abouzid, Khaled |
| 2015 | Discovery of Potent Antiproliferative Agents Targeting EGFR Tyrosine Kinase Based on the Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine Scaffold | Aziz, Yasmine Mohamed Abdel; Said, Mohamed Mokhtar; El Shihawy, Hosam Ahmed; Tolba, Mai ; Abouzid, Khaled |
| Aug-2021 | Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations | Elrazaz, Eman ; Serya, Rabah A T ; Ismail, Nasser S M; Albohy, Amgad; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 15-Apr-2016 | Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents | Aziz, Marwa A; Serya, Rabah A T ; Lasheen, Deena S. ; Mansour, Ahmed M; Ahmed Esmat ; Singab A. ; Khaled A M Abouzid ; Abdel-Aziz, Amal Kamal |
| 7-Jul-2017 | Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities | Abouzid, Khaled ; Al-Ansary, Ghada H; El- naggar, Abeer |
| 26-Aug-2020 | Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer | Mansour, Mai A; Lasheen, Deena S. ; Gaber, Hatem M; Khaled A M Abouzid |
| 2016 | Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents | Aziz, M.A. ; Serya, RAT; Lasheen, DS; Abouzid, Khaled ; Serya, Rabah |
| 2022 | Hands-on synthetic approaches and biological activities of anthranilic acid derivatives: A mini-review | Nasr, Tamer; Aboshanab, Ahmed; Abouzid, Khaled ; Zaghary, Wafaa |
| 25-Oct-1996 | Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand | Khanolkar, A D; Abadji, V; Lin, S; Hill, W A; Taha, G; Abouzid, Khaled ; Meng, Z; Fan, P; Makriyannis, A |
| 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| 13-Nov-2018 | Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis | Ge, Xin; Pan, Min-Hong; Wang, Lin; Li, Wei; Jiang, Chengfei; He, Jun; Abouzid, Khaled ; Liu, Ling-Zhi; Shi, Zhumei; Jiang, Bing-Hua |
| Mar-2022 | Identification of a promising hit from a new series of pyrazolo[1,5-a]pyrimidine based compounds as a potential anticancer agent with potent CDK1 inhibitory and pro-apoptotic properties through a multistep in vitro assessment | Elgiushy, Hossam R; Mohamed, Sameh H; Sawaf, Hussein; Hassan, Zeinab; Abou-Taleb, Nageh A; El-Labbad, Eman M; Hassan, Ashraf S; Abouzid, Khaled A M; Abouzid, Khaled ; Ali Taha, Heba |
| Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
| 8-Mar-2022 | Identification of novel furo[2,3-d]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation | Mansour, Mai A; Oraby, Mamdouh A; Muhammad, Zeinab A; Lasheen, Deena ; Gaber, Hatem M; Khaled A M Abouzid |
| 2019 | Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation | Shalaby, Menna-Allah; Dokla, Eman ; Serya, Rabah ; Abouzid, Khaled |
| Jul-2013 | In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2 | Ahmed, Marawan; Sadek, Maiada M; Abouzid, Khaled ; Wang, Feng; Serya, Rabah |
| 1-Dec-2021 | Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer | Dokla, Eman ; Abdel-Aziz, Amal Kamal ; Milik, Sandra N.; Mahmoud, Amr H.; Saadeldin, Mona Kamal; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| 2022 | Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno[2,3-d]pyrimidine-based EGFR inhibitors | Milik, SN; Abdel-Aziz, AK; El-Hendawy, MM; El-Gogary, RI; Saadeldin, MK; Minucci, S; Klein, CD; Abouzid, Khaled |
| 1-Apr-2012 | Integrated structure-based activity prediction model of benzothiadiazines on various genotypes of HCV NS5b polymerase (1a, 1b and 4) and its application in the discovery of new derivatives | Ismail, Mohamed A H; Abou El Ella, Dalal ; Khaled A M Abouzid ; Mahmoud, Amr H |
| 1-Sep-2020 | An investigative study of antitumor properties of a novel thiazolo[4,5-d]pyrimidine small molecule revealing superior antitumor activity with CDK1 selectivity and potent pro-apoptotic properties | Mohamed, Sameh H; Elgiushy, Hossam R; Hammad, Sherif F; Abou-Taleb, Nageh A; A M Abouzid, Khaled; Abouzid, Khaled ; Hassan, Zeinab; Ali Taha, Heba |
| 1-Sep-2011 | Labeling and Biological Evaluation of 99mTc-Cefotaxime for infective Inflammation Diagnosis | M. A. Motaleb; A. A. El Mohty; M. A. El Garhy; Mohamed abdel Hamid Ismail; Abouzid, Khaled ; Tamer M. Sakr |
| 15-Feb-2006 | Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists | Ismail, Mohamed A H; Aboul-Enein, Mohamed N Y; Abouzid, Khaled ; Serya, Rabah A T |
| 1-Dec-2013 | Ligand design, synthesis and biological anti-HCV evaluations for genotypes 1b and 4a of certain 4-(3- & 4-[3-(3,5-dibromo-4-hydroxyphenyl)-propylamino] phenyl) butyric acids and 3-(3,5-dibromo-4-hydroxyphenyl)-propylamino- acetamidobenzoic acid esters | Ismail, Mohamed Abdel Hamid; Mohamed, Nasser Saad; Dokla, Eman ; Khaled A M Abouzid |
| 2021 | Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies | Abdel-Bar, Hend Mohamed; Abdallah, Inas A.; Fayed, Marwa A. A.; Moatasim, Yassmin; Mostafa, Ahmed; El-Behairy, Mohammed Farrag; Elimam, Hanan; Elshaier, Yaseen A. M. M.; Abouzid, Khaled |
| 2009 | Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity | Ismail, MAH; Lehmann, J; Abou El Ella, D.A. ; Albohy, A; Abouzid, Khaled |
| Nov-2017 | Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities | Ghith, Amna; Ismail, Nasser S M; Youssef, Khairia; Abouzid, Khaled |
| 2021 | Medicinal Chemistry Strategies Towards SO2 Donors as Research Tools and Potential Therapeutics | El-Labbad, Eman M; Ji, Xingyue; Abouzid, Khaled ; Wang, Binghe |
